Primary care providers’ use of pharmacist support for delivery of pharmacogenetic testing-Reference-Cited by-同舟云学术

Primary care providers’ use of pharmacist support for delivery of pharmacogenetic testing

Published:2017-03 Issue:4 Volume:18 Page:359-367
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Haga Susanne B¹,Mills Rachel¹,Moaddeb Jivan¹,Allen LaPointe Nancy²,Cho Alex³,Ginsburg Geoffrey S¹

Affiliation:

1. Duke Center for Applied Genomics & Precision Medicine, Duke University, Durham, NC, USA

2. Duke Clinical Research Institute, Duke University, Durham, NC, USA

3. Department of Medicine, Duke University, Durham, NC, USA

Abstract

Aim: To investigate provider utilization of pharmacist support in the delivery of pharmacogenetic testing in a primary care setting. Methods: Two primary care clinics within Duke University Health System participated in the study between December 2012 and July 2013. One clinic was provided with an in-house pharmacist and the second clinic had an on-call pharmacist. Results: Providers in the in-house pharmacist arm consulted with the pharmacist for 13 of 15 cases, or about one of every four patients tested compared with one of every 7.5 patients in the on-call pharmacist arm. A total of 63 tests were ordered, 48 by providers in the pharmacist-in-house arm. Conclusion: These findings suggest that the availability of an in-house pharmacist increases the likelihood of pharmacogenetic test utilization.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2016-0177

Reference40 articles.

1. Impact of a personal CYP2D6 testing workshop on physician assistant student attitudes toward pharmacogenetics

2. The current and future state of pharmacogenomics medical education in the USA

3. Hing E, Uddin S. NHS Data Brief, No. 47: visits to primary care delivery sites: United States (2008). www.cdc.gov/nchs/data/databriefs/db47.pdf.

4. Primary care physicians' knowledge of and experience with pharmacogenetic testing

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Essential elements of physical fitness analysis in male adolescent athletes using machine learning;PLOS ONE;2024-04-02

2. Assessment of the current status of real-world pharmacogenomic testing: informed consent, patient education, and related practices;Frontiers in Pharmacology;2024-02-08

3. Public perceptions of pharmacogenomic services in Ireland - Are people with chronic disease more likely to want service availability than those without? A questionnaire study;Exploratory Research in Clinical and Social Pharmacy;2022-12

4. General practitioners’ (GPs) experience, attitudes and needs on clinical genetic services: a systematic review;Family Medicine and Community Health;2022-11

5. A systematic review of pharmacogenetic testing in primary care: Attitudes of patients, general practitioners, and pharmacists;Research in Social and Administrative Pharmacy;2021-12